title: Ergotamine-induced cardiovascular toxicity: mechanisms and clinical significance.
authors.forename: Pawel
authors.initials: P
authors.lastname: Rostoff
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Gajos
authors.forename: Pawel
authors.initials: P
authors.lastname: Latacz
authors.forename: Milosz
authors.initials: M
authors.lastname: Wozniczko
authors.forename: Jerzy
authors.initials: J
authors.lastname: Matysek
authors.forename: Wieslawa
authors.initials: W
authors.lastname: Piwowarska
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000503:physiopathology; D018360:Crystallography, X-Ray; D004878:Ergotamine / Q000737:chemistry / Q000506:poisoning* / Q000627:therapeutic use; D004881:Ergotism / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D014662:Vasoconstrictor Agents / Q000737:chemistry / Q000506:poisoning* / Q000627:therapeutic use
chemical_list: D014662:Vasoconstrictor Agents; D004878:Ergotamine